You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
|
---|---|
Published in |
Frontiers in Pharmacology, January 2022
|
DOI | 10.3389/fphar.2021.807548 |
Pubmed ID | |
Authors |
Amelia D. Dahlén, Giovanna Dashi, Ivan Maslov, Misty M. Attwood, Jörgen Jonsson, Vladimir Trukhan, Helgi B. Schiöth |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 13% |
Canada | 2 | 13% |
Saudi Arabia | 1 | 7% |
Germany | 1 | 7% |
United States | 1 | 7% |
United Kingdom | 1 | 7% |
Switzerland | 1 | 7% |
Unknown | 6 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 47% |
Scientists | 4 | 27% |
Practitioners (doctors, other healthcare professionals) | 3 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 242 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 242 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 22 | 9% |
Researcher | 18 | 7% |
Student > Bachelor | 16 | 7% |
Student > Master | 14 | 6% |
Student > Postgraduate | 9 | 4% |
Other | 29 | 12% |
Unknown | 134 | 55% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 21 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 20 | 8% |
Medicine and Dentistry | 16 | 7% |
Chemistry | 11 | 5% |
Agricultural and Biological Sciences | 9 | 4% |
Other | 26 | 11% |
Unknown | 139 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2023.
All research outputs
#1,171,485
of 25,721,020 outputs
Outputs from Frontiers in Pharmacology
#445
of 19,995 outputs
Outputs of similar age
#29,100
of 518,476 outputs
Outputs of similar age from Frontiers in Pharmacology
#20
of 1,162 outputs
Altmetric has tracked 25,721,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,995 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 518,476 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 1,162 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.